Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis by Sergio Iannazzo, Lorenzo Pradelli

“…Scope of the present study is to investigate the pharmacoeconomic performance of the treatment with solifenacin, when compared to tolterodine and placebo, in Italian patients with OAB. …”
Get full text

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy by Reshetko O.V., Lutsevich К.А., Nelyubova 0.I.

Subjects: Get full text

PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING by M. V. Protsenko, N. I. Koroleva

Subjects: Get full text

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC ANALYSIS OF TREATMENT OF ENDOMETRIT IN-HOSPITAL by L. Yu. Chernikova, M. V. Belousov

“…Pharmacoepidemiological and pharmacoeconomical analysis of endometrit drug therapy at special treatment-and-prophylactic institutions of the city of Tomsk. …”
Get full text

A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia by I. S. Krysanov, V. Yu. Ermakova

Subjects: Get full text

The role of pharmacoeconomics in current Indian healthcare system by Akram Ahmad, Isha Patel, Sundararajan Parimilakrishnan, Guru Prasad Mohanta, HaeChung Chung, Jongwha Chang

Subjects: “…Drug costs; drug industry; formularies; health insurance; pharmacoeconomics…”
Get full text

Abstracts Presented at the 2022 International Pharmacoeconomics Forum

Get full text

Pharmacoeconomic analysis of perampanel for resistance partial epilepsy by D. Yu. Belousov, E. V. Afanasyeva, E. A. Efremova

“…Th e prevalence of partial epilepsy in Russia reached 325 thousand patients, with resistant to therapy about 276 thousand. Objective. Pharmacoeconomic analysis (PHe) was conducted for perampanel use in patients older than 14 years with resistance partial epilepsy with or without secondary generalization in Russian Federation. …”
Get full text

3rd Annual International Pharmacoeconomic Forum Highlights by Francisco Rocha Gonçalves

Get full text

Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer by Yu. Yu. Petukhova, E. V. Eliseeva, M. V. Volkov, O. N. Li, A. G. Petukhova

“…Objective: to perform a pharmacoeconomic evaluation of the effectiveness of therapies for metastatic colorectal cancer (mCRC) based on real practical data on medical help for patients with this disease.Material and methods. …”
Get full text

Light at the end of the tunnel ? : The Great Indian Pharmacoeconomics story. by Karan eThakkar, Gauri eBilla

Subjects: Get full text

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina

“…The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy with antipsychotics in outpatients diagnosed with schizophrenia.Materials and methods. …”
Get full text

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis by R. I. Yagudina, M. M. Murashko

Subjects: “…pharmacoeconomics…”
Get full text

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis by N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova

Subjects: “…pharmacoeconomics…”
Get full text

Pharmacoeconomic analysis of Movalis in patients with osteoarthritis and rheumatoid arthritis by E. S. Tsvetkova, D. Yu. Belousov, E. V. Afanasyeva

Subjects: Get full text

Pharmacoeconomic Evaluation of Costs of Myelomeningocele and Meningocele Treatment and Screening by Hoxha M, Malaj V, Zappacosta B, Firza N

Subjects: Get full text

Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions by Fernanda S. Tonin, Ignacio Aznar-Lou, Vasco M. Pontinha, Roberto Pontarolo, Fernando Fernandez-Llimos

“…Yet, the evidence of the economic impact of the pharmacist in decreasing total health expenditures, unnecessary care, and societal costs relies on well-performed, reliable, and transparent economic evaluations, which are scarce. Pharmacoeconomics is a branch of health economics that usually focuses on balancing the costs and benefits of an intervention towards the use of limited resources, aiming at maximizing value to patients, healthcare payers and society through data driven decision making. …”
Get full text

PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION by R. I. Yagudina, I. Yu. Zinchuk

Subjects: Get full text

Analysis of cephalosporins available in India: A pharmacoeconomic perspective by Ritesh Churihar, Hemant Tanwani, Kamayani Gupta

Get full text

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE by Yu. M. Lopatin, E. Yu. Lopatina

“…The only Russian study on pharmacoeconomics of eplerenone used data from studies in both groups. …”
Get full text